GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » Inventories, Finished Goods

111 (YI) Inventories, Finished Goods : $0 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is 111 Inventories, Finished Goods?

111's quarterly finished goods increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($199 Mil) but then declined from Dec. 2023 ($199 Mil) to Mar. 2024 ($0 Mil).

111's annual finished goods increased from Dec. 2021 ($176 Mil) to Dec. 2022 ($215 Mil) but then declined from Dec. 2022 ($215 Mil) to Dec. 2023 ($199 Mil).


111 Inventories, Finished Goods Historical Data

The historical data trend for 111's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 Inventories, Finished Goods Chart

111 Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial 69.33 117.22 176.02 215.00 198.79

111 Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 198.79 -

111 Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


111 (YI) Business Description

Industry
Traded in Other Exchanges
Address
No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.